When an rising biotech making a first-in-class, best-in-class treatment for von Willebrand sickness (VWD) partnered with Worldwide, they confronted an issue: to quickly set up the optimum dose for his or her upcoming look at.
A few key achievements to highlight:
- Met enrollment goals no matter challenges
- Delivered data for DMC evaluation inside 10 days
- Activated the first OLE web site inside 32 days
Study the overall case look at to learn the way our versatile choices can optimize your subsequent Half 1b look at.
Keep forward of the curve with NextBusiness 24. Discover extra tales, subscribe to our publication, and be part of our rising neighborhood at nextbusiness24.com